Articles From: Aurinia Pharmaceuticals to Initiate an Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers to Australia’s Largest Life Insurer Partners with Healthways to Promote Healthier Behaviors


2015/2/9
Aurinia Pharmaceuticals Inc. (the “Company”) (NASDAQ:AUPH) (TSX:AUP) today announced that it will initiate an open label, exploratory study to assess the short term predictors of response using voclosporin in combination with mycophenolate mofetil in patients with active lupus nephritis.
Sign-up for Aurinia Pharmaceuticals to Initiate an Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers investment picks
2015/1/29
Aurinia Pharmaceuticals, Inc., (NASDAQ: AUPH / TSX: AUP) today announced that its President and Chief Executive Officer Stephen Zaruby will present a corporate overview of the company at the BIO CEO Investor Conference, taking place February 9th-10th in New York at the Waldorf-Astoria Hotel.
Sign-up for Aurinia Pharmaceuticals to Present at the BIO CEO Investor Conference investment picks
2015/2/11
Basel, Switzerland, Feb.
Sign-up for Auris Medical Announces Recently Granted Patent in China for the Treatment of Tinnitus investment picks
2015/1/14
ZUG, Switzerland, Jan.
Sign-up for Auris Medical Holding AG Achieves 50% Enrolment Milestone in Post-Acute Tinnitus Stratum of TACTT3 Clinical Trial investment picks
2014/12/3
ZUG, Switzerland, Dec.
Sign-up for Auris Medical Q3 2014 Earnings Release investment picks
2014/12/1
ZUG, Switzerland, Dec.
Sign-up for Auris Medical to Announce Third Quarter 2014 Financial Results and Host Conference Call on Wednesday, December 3, 2014 investment picks
2015/2/4
ZUG, Switzerland, Feb.
Sign-up for Auris Medical to present at the Leerink Global Healthcare Conference investment picks
2015/1/27
By Ross Kelly SYDNEY--Aurizon Holdings Ltd.
Sign-up for Aurizon Coal-Haulage Volumes Edge Back investment picks
2015/2/15
By Rhiannon Hoyle SYDNEY--Aurizon Holdings Ltd.
Sign-up for Aurizon First-Half Net Profit Nearly Triples investment picks
2015/1/7
Focused on more coordinated and quality health care outcomes for patients, Humana Inc. (NYSE:HUM) and Aurora Health Care announced today that they have entered into a new Accountable Care agreement for Medicare Advantage members throughout the eastern Wisconsin and northern Illinois region.
Sign-up for Aurora Health Care and Humana Join Forces on Accountable Care Agreement for 2015 investment picks
2014/12/2
NEW YORK, Dec.
Sign-up for Auryxia(TM) (Ferric Citrate) Phase 2 Data Published in the American Journal of Kidney Disease investment picks
2014/12/22
LA JOLLA, Calif., Dec.
Sign-up for Auspex Added to the NASDAQ Biotechnology Index investment picks
2015/1/12
SD-809 Met Primary Outcome Measure, Showed No Clinically Significant QT Prolongation LA JOLLA, Calif., Jan.
Sign-up for Auspex Announces Favorable Topline Results From Thorough QT Clinical Trial of SD-809 investment picks
2014/12/16
Pivotal Phase 3 Trial Met Primary and Multiple Key Secondary Efficacy Endpoints; Favorable Safety and Tolerability Demonstrated ARC-HD Trial Shows Successful Maintenance of Chorea Control After Switch to SD-809 NDA Submission Planned by Mid-2015 Conference Call Scheduled for 4:30 PM ET / 1:30 PM PT Today LA JOLLA, Calif., Dec.
Sign-up for Auspex Announces Positive Topline Results From Registration Trial of SD-809 for Chorea Associated With Huntington's Disease investment picks
2015/1/23
LA JOLLA, Calif., Jan.
Sign-up for Auspex Announces Pricing of Follow on Offering investment picks
2015/1/21
LA JOLLA, Calif., Jan.
Sign-up for Auspex Announces Proposed Public Offering of Common Stock investment picks
2015/1/12
Auspex to Acquire Remaining Worldwide Rights to SD-1077 Through Purchase of Imphar AG LA JOLLA, Calif., Jan.
Sign-up for Auspex Pharmaceuticals Announces SD-1077 Program for the Potential Treatment of Parkinson's Disease and Related Movement Disorders investment picks
2015/2/3
LA JOLLA, Calif., Feb.
Sign-up for Auspex Pharmaceuticals Completes Enrollment in a Pivotal Clinical Trial of SD-809 in Tardive Dyskinesia investment picks
2015/2/2
LA JOLLA, Calif., Feb.
Sign-up for Auspex to Present at the 2015 Leerink Global Healthcare Conference investment picks
2015/2/23
LA JOLLA, Calif., Feb.
Sign-up for Auspex to Present at the Cowen Healthcare Conference investment picks
2015/1/5
LA JOLLA, Calif., Jan.
Sign-up for Auspex to Present at the J.P. Morgan Healthcare Conference investment picks
2014/12/1
LA JOLLA, Calif., Dec.
Sign-up for Auspex to Present at the Piper Jaffray Healthcare Conference investment picks
2015/2/2
Cigna (NYSE: CI) and Austin Regional Clinic have launched a collaborative care initiative to improve access to health care, enhance care coordination , and achieve the goal of improved health , affordability and customer experience .
Sign-up for Austin Regional Clinic and Cigna Form Collaborative Care Program to Improve Health and Lower Costs in Austin investment picks
2015/2/10
By Rob Taylor CANBERRA, Australia--Australia has tightened rules for foreign investment in agricultural land in an effort to soothe growing concern about prime farmland passing into foreign hands.
Sign-up for Australia Tightens Rules on Foreign Investment in Agricultural Land investment picks
2015/2/11
By Ross Kelly SYDNEY--Santos Ltd.
Sign-up for Australia's Santos in A$1.6 Billion Asset Writedown investment picks
2015/2/12
By Ross Kelly SYDNEY--Australia's biggest telecommunications company exploited the buzz around Apple Inc.'s latest iPhone to lure more mobile customers in the first half of its fiscal year, but failed to reverse slowing growth in an increasingly saturated cellphone market.
Sign-up for Australia's Telstra Faces Slowing Mobile Growth investment picks
2015/2/11
By Ross Kelly SYDNEY--Telstra Corp.
Sign-up for Australia's Telstra Rings Up 22% Profit Boost investment picks
2014/12/16
TAL , Australia’s largest specialty life insurer, has partnered with global well-being improvement leader Healthways, Inc. (NASDAQ: HWAY), to offer well-being improvement solutions for up to three million members that TAL covers through its employer and pension-based partnerships.
Sign-up for Australia’s Largest Life Insurer Partners with Healthways to Promote Healthier Behaviors investment picks
Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Aurinia Pharmaceuticals to Initiate an Open Label Clinical Study to Investigate the Impact of Voclosporin on Lupus Nephritis Biomarkers to Australia’s Largest Life Insurer Partners with Healthways to Promote Healthier Behaviors
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent